Valuation: TransMedics Group, Inc.

Market Cap 3.25B 2.78B 2.6B 2.38B 4.49B 311B 4.54B 30.79B 11.97B 156B 12.19B 11.92B 516B P/E 2026 *
67.2x
P/E 2027 * 42.6x
Enterprise Value 3.21B 2.75B 2.57B 2.35B 4.43B 307B 4.48B 30.41B 11.82B 154B 12.04B 11.77B 510B EV / Sales 2026 *
4.32x
EV / Sales 2027 * 3.54x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.23%
1 week+5.94%
Current month+22.34%
1 month+29.53%
3 months+35.78%
6 months-32.07%
Current year-23.06%
1 week 90.15
Extreme 90.15
95.18
1 month 68
Extreme 68
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap.
8/17/26 A Don

Chairman

-18,000 0.0528%
7/10/26 A Free

Chief Financial Officer

43,399 0.1273%
7/10/26 A Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-1.23%+5.94%-21.90%+50.12% 3.25B
-0.08%+7.38%+25.75%+16.86% 232B
-1.71%+6.16%+1.56%-15.16% 151B
-1.38%-4.29%-21.55%+30.78% 132B
-2.70%-4.71%-53.84%-2.82% 71.03B
-1.84%+0.48%-16.60%-12.72% 52.46B
+0.79%-0.34%+10.60%+20.65% 52.16B
-3.50%+3.35%+26.14%+28.40% 43.33B
+0.01%+0.74%+35.92%+51.47% 40.36B
-0.84%+2.51%-1.37%+8.42% 33.51B
Average -0.72%+2.24%-1.53%+17.60% 81.18B
Weighted average by Cap. -0.61%+2.79%+2.10%+11.89%

Financials

2026 *2027 *
Net sales 742M 636M 595M 544M 1.03B 71.02B 1.04B 7.04B 2.74B 35.66B 2.78B 2.72B 118B 875M 750M 701M 641M 1.21B 83.76B 1.22B 8.3B 3.23B 42.06B 3.28B 3.21B 139B
Net income 51.99M 44.55M 41.68M 38.11M 71.91M 4.98B 72.67M 493M 192M 2.5B 195M 191M 8.27B 89.08M 76.34M 71.42M 65.3M 123M 8.53B 125M 845M 329M 4.28B 334M 327M 14.17B
Net Debt -40.26M -34.5M -32.28M -29.51M -55.69M -3.85B -56.28M -382M -149M -1.94B -151M -148M -6.4B -146M -125M -117M -107M -201M -13.95B -204M -1.38B -537M -7B -547M -535M -23.17B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
24/08/26 $93.60 -1.23% 770,374
21/08/26 $94.77 +4.31% 628,723
20/08/26 $90.85 -3.32% 589,598
19/08/26 $93.97 +3.62% 703,325
18/08/26 $90.69 +2.65% 778,302
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
93.60USD
Average target price
97.30USD
Spread / Average Target
+3.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock